Literature DB >> 8474651

Significance of the rate of systemic change in blood pressure on the short-term autoregulatory response in normotensive and spontaneously hypertensive rats.

P Barzó1, F Bari, T Dóczi, G Jancsó, M Bodosi.   

Abstract

Cerebral autoregulation, the physiological regulatory mechanism that maintains a constant cerebral blood flow (CBF) over wide ranges of arterial blood pressure, was investigated in normotensive and spontaneously hypertensive rats by means of laser-Doppler flowmetry. Systemic arterial hypertension was produced at rates ranging from 0.02 mm Hg/second to 11 mm Hg/second by constant infusion of epinephrine and norepinephrine. Systemic arterial hypotension was produced at rates ranging from -0.03 mm Hg/second to -12 mm Hg/second, either by bleeding the animals into a reservoir or by compressing the abdomen. In those cases with a low rate of change in systemic arterial blood pressure (SABP), the measurements lasted for 5 +/- 2 minutes, and in those with a high rate of change in SABP, measurements lasted for 40 +/- 30 seconds. The purpose was to record the time of onset and course of autoregulation in the basal ganglia in response to slow or rapid changes in SABP. CBF in the basal gray matter remained at baseline values (i.e., autoregulation was functioning) if the rate of increase of SABP did not exceed a critical value (0.10 mm Hg/second in the normotensive rats; 0.35 mm Hg/second in the spontaneously hypertensive rats). When hypertension was produced at faster rates, CBF followed arterial blood pressure passively, and no autoregulatory response was observed for 2 +/- 1 minutes. Hypotension did not change the baseline CBF when it was not produced at a rate faster than -0.4 mm Hg/second in normotensive rats and -0.15 mm Hg/second in spontaneously hypertensive rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8474651     DOI: 10.1227/00006123-199304000-00018

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Simultaneous bedside assessment of global cerebral blood flow and effective cerebral perfusion pressure in patients with intracranial hypertension.

Authors:  M Jägersberg; C Schaller; J Boström; B Schatlo; M Kotowski; C Thees
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

2.  Effect of acupuncture-like stimulation on cortical cerebral blood flow in aged rats.

Authors:  Sae Uchida; Fusako Kagitani
Journal:  J Physiol Sci       Date:  2014-10-10       Impact factor: 2.781

3.  Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation.

Authors:  Christina H Liu; Doug N Greve; Guangping Dai; John J A Marota; Joseph B Mandeville
Journal:  Neuroimage       Date:  2006-12-13       Impact factor: 6.556

4.  Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study.

Authors:  F Bari; G Horváth; G Benedek
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

5.  Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat.

Authors:  M Kobari; Y Fukuuchi; M Tomita; N Tanahashi; S Konno; H Takeda
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Transient Hypoperfusion to Ischemic/Anoxic Spreading Depolarization is Related to Autoregulatory Failure in the Rat Cerebral Cortex.

Authors:  Ákos Menyhárt; Dániel Péter Varga; Orsolya M Tóth; Péter Makra; Ferenc Bari; Eszter Farkas
Journal:  Neurocrit Care       Date:  2021-12-02       Impact factor: 3.532

Review 7.  PACAP and its receptors in cranial arteries and mast cells.

Authors:  Inger Jansen-Olesen; Sara Hougaard Pedersen
Journal:  J Headache Pain       Date:  2018-02-20       Impact factor: 7.277

8.  Influence of hypertension classification on hypertensive intracerebral hemorrhage location.

Authors:  Jun Shen; FengBao Guo; Peng Yang; Feng Xu
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-10-05       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.